首页> 外国专利> APPLICATION OF QUERCETIN IN PREPARATION OF DRUG FOR PREVENTION AND TREATMENT OF DRUG-INDUCED LIVER INJURY

APPLICATION OF QUERCETIN IN PREPARATION OF DRUG FOR PREVENTION AND TREATMENT OF DRUG-INDUCED LIVER INJURY

机译:槲皮素在预防和治疗药物引起的肝损伤的药物制备中的应用

摘要

The present invention relates to a medical use of quercetin in prevention and treatment of drug-induced acute liver injury, and in particular, to application of the quercetin in preparation of a drug for prevention and treatment of liver injury caused by acetaminophen. Animal experiments prove that the quercetin controls abnormal rise in biochemical indicators related to acetaminophen-induced liver functions and changes in pathological structures, and increases the content of in-vivo antidote GSH in acetaminophen-induced liver tissue injury; the quercetin is an oral preparation or injection preparation, the administration dosage may be changed according to the age, the weight, the intake amount of acetaminophen, the arrangement of a treatment course and the like of a patient, a recommended administration dosage for a person is 40 mg/kg/d, and an oral administration mode is recommended; the quercetin can effectively resist liver injury caused by acetaminophen, and can be used for preparing a drug for treating liver injury caused by acetaminophen.
机译:本发明涉及槲皮素在预防和治疗药物引起的急性肝损伤中的医学用途,尤其涉及槲皮素在制备用于预防和治疗由对乙酰氨基酚引起的肝损伤的药物中的应用。动物实验证明,槲皮素可控制与对乙酰氨基酚引起的肝功能和病理结构变化有关的生化指标异常升高,并增加对乙酰氨基酚引起的肝组织损伤中体内解毒剂GSH的含量;槲皮素为口服制剂或注射制剂,给药剂量可根据患者的年龄,体重,对乙酰氨基酚的摄入量,治疗过程的安排等,人的推荐给药剂量而改变。为40 mg / kg / d,建议口服给药;槲皮素能有效抵抗对乙酰氨基酚引起的肝损伤,可用于制备治疗对乙酰氨基酚引起的肝损伤的药物。

著录项

  • 公开/公告号WO2020186683A1

    专利类型

  • 公开/公告日2020-09-24

    原文格式PDF

  • 申请/专利权人 GUANGDONG PHARMACEUTICAL UNIVERSITY;

    申请/专利号WO2019CN98902

  • 发明设计人 CHEN ALI;

    申请日2019-08-01

  • 分类号A61K31/352;A61P1/16;

  • 国家 WO

  • 入库时间 2022-08-21 11:09:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号